Please do not leave this page until complete. This can take a few moments.
Hologic is relaunching an aesthetic health device four months after pulling it from the market after the U.S. Food and Drug Administration issued a warning about the overstated health benefits of a similar device.
The TempSure Vitalia device, made and marketed by Hologic subsidiary Cynosure, has returned to the market, Hologic announced in a press release last week.
The company said it has been working with the FDA over the last several months to review and update the marketing of the product to ensure consistency with guidelines.
The move to suspend the Vitalia program in August after after another Cynosure device, the MonaLisa Touch, was the subject of a letter from the FDA about some inconsistencies in its approved use and its actual use.
The FDA said the device was cleared for a variety of uses, but not for several uses listed on the device's website, including for vaginal and vulvar health, menopause symptom relief, vaginal wall healing and other vaginal uses.
The MonaLisa Touch continues to be marketed and sold, Hologic said.
“We’re pleased to reintroduce TempSure Vitalia and to continue offering MonaLisa Touch to provide clinically strong products for women’s wellness,” division president Kevin Thornal said in a statement. “Cynosure is the only medical aesthetic manufacturer to offer two different energy-based modalities for women’s wellness — radiofrequency and CO2 — and we remain committed to advancing women’s pelvic health around the globe.”
Last week’s announcement was made in conjunction with the North American launch of another device, the TempSure Surgical Technology, offering the ability to perform both surgical and non-surgical aesthetic procedures on a single device.
The technology harnesses a 300-watt and 5-MHz radiofrequency platform to enable precise incisions with minimal lateral damage to surrounding tissues to allow for quicker recovery and better healing in patients.
The device can be used in a variety of specialty fields, including plastic surgery, dermatology, gynecology and ophthalmology, the company said.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments